Abstract RF7-01: Elacestrant in combination with everolimus or abemaciclib in patients with ER+/HER2- locally advanced or metastatic breast cancer (mBC): phase 2 results from ELEVATE, an open-label, umbrella study
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institutions: City Of Hope National Medical Center, City of Hope, Dana-Farber Cancer Institute, NYU Langone Health, New York University, Rabin Medical Center, University of Wisconsin–Madison, AdventHealth Orlando, AdventHealth, Highlands Oncology Group, Harvard University, Massachusetts General Hospital, Cancer Care Northwest, Baylor University Medical Center, University of Milan, European Institute of Oncology, IDCQ Hospitales y Sanidad, S.L.U., Menarini Group (Italy), The University of Texas at San Antonio Health Science Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129252518